|
|
|
|
The Five Warning Signs of Alzheimer's Disease
Nancy Travers You visited your parents recently and your mom's behavior worried you.She didn't seem her usual self - she was forgetful, repeating herself in conversation and over the weekend she seemed to misplace more items than is usual. You want to just...
|
|
|
Using New Approach, Mayo Clinic Researchers Find Level of Gene Alters Risk of Alzheimer's Disease
Researchers believe it's not enough to look for disease risk genes?understanding expression levels of genes is important, too JACKSONVILLE, Fla? Using sophisticated techniques that scan the genomes of patients, researchers at the Mayo Clinic campus in...
|
|
|
Medivation Reports Fourth Quarter and Year-End 2009 Financial Results and Provides Corporate Update
SAN FRANCISCO, March 15 /PRNewswire-FirstCall/ -- Medivation, Inc.(NASDAQ:MDVN) today provided a corporate update and reported its financial results for the year ended December 31, 2009. 'We are disappointed by the results of the Phase 3 CONNECTION trial...
|
|
|
Brain Plaques May Explain Higher Risk of AlzheimerEURs Disease Based on MotherEURs History
New imaging tool could eventually lead to earlier detection among pre-symptomatic individuals A family history of Alzheimer's disease is one of the biggest risk factors for developing the memory-robbing disease, which affects more than 5 million Americans...
|
|
|
How the demons of dementia possess and damage brain cells
A study from EPFL's (Ecole Polytechnique Federale de Lausanne) Laboratory of Neuroenergetics and Cellular Dynamics in Lausanne Switzerland, published today in the Journal of Neuroscience, may lead to new forms of treatment following a better understanding of...
|
|
|
Early Identification Of Alzheimer's Disease With PET Scan
Westside Medical Associates of Los Angeles and Westside Medical Imaging (WMI) of Beverly Hills announce the benefit of early positron emission tomography (PET) scanning to identify Alzheimer's in its early more treatable phase.According to Dr. Norman...
|
|
|
Senior News: Social Security initiative helps early-onset Alzheimer's patients
The Social Security Administration has added early-onset (younger-onset) Alzheimer's disease to its Compassionate Allowances Initiative, which will allow people under age 65, diagnosed with Alzheimer's, to apply for and receive benefits.The...
|
|
|
Brain plaques may explain higher risk of Alzheimer's based on mom's history
Two views of a composite image of the brains analyzed in the study compare the average increases in amyloid-beta deposits in volunteers with a maternally or paternally inherited risk of Alzheimer's, compared to counterparts with no family history of...
|
|
|
Campaign to cut doctor waiting times for Alzheimer's patients launches
London: A new campaign, titled Memory Problems?,is launched today by ex GMTV presenter, Fiona Phillips today to help people recognise the early signs and symptoms of Alzheimers disease and distinguish these from the normal changes that occur with ageing....
|
|
|
Alzheimers Disease: Another Promising Drug Bites the Dust
A recent article on Alzheimers disease (AD) reviews the pathogenesis of this increasingly common disorder.1 Various agents are in development which have potential for arresting the disease process and perhaps improve the progressive cognitive decline...
|
|
|
Bristol's Early Alzheimer's Research Takes A Different Tack
Remember Me Already a subscriber?Sign in or register to create an account? Search Include Synonyms PUBLICATIONS: Check All | Uncheck All 'The Pink Sheet' 'The Rose Sheet' Pharmaceutical Approvals Monthly 'The Gold Sheet' 'The Gray Sheet' Health News Daily ...
|
|
|
European orphan drug status for Allon's neuroprotective drug candidate davunetide
Allon Therapeutics Inc.announced that its lead neuroprotective drug candidate, davunetide, has been granted Orphan Drug Status in the European Union (EU) for the treatment of Progressive Supranuclear Palsy (PSP), a rapidly-progressing and fatal degenerative...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
PHILADELPHIA, March 18 /PRNewswire-USNewswire/ -- The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug...
|
|
|
Art stimulates conversation with Alzheimer's patients
Jeanne Quigley of Alzheimers Services of Cape Cod and the Islands talks about art by Guyer Barn last week.Cape Cod Times/Merrily Lunsford One of the first things that Alzheimer's disease robs an individual of is the ability to remember words and...
|
|
|
Mental Health 101: Where can I find neurologists in New York for dementia and Alzheimers disease
Mental Health 101: Where can I find neurologists in New York for dementia and Alzheimer's disease March 17, 11:19 PMNY Healthy Living ExaminerMarmee Cosico Comment Subscribe Get alerts when there is a new article from the NY Healthy Living Examiner.
|
|
|
Level of gene could change Alzheimer threat
Genes seem to play a very important role in either augmenting the disorder or help protect against it.By means of modern methods that may screen the genomes of patients, scientists at the Mayo Clinic campus in Florida have discovered that a gene could either...
|
|
|
Alzheimer's disease: Gene expression level influences promotion of disorder or protection against development
Researchers believe it's not enough to look for disease risk genes -- understanding expression levels of genes is important, too Using sophisticated techniques that scan the genomes of patients, researchers at the Mayo Clinic campus in Florida have found that a...
|
|
|
Alzheimer Drug Test Result From J&J May Be Pushed Back to 2012
March 18 (Bloomberg) -- One of the most eagerly anticipated studies of a drug for Alzheimers disease may not yield results until 2012, two years later than had been forecast.Johnson & Johnson took over development of the medicine, bapineuzumab,...
|
|
|
J&J rattles analysts with long delay for Alzheimer's program
J&J has rattled analysts with a new timeline for the Alzheimer's drug bapineuzumab, saying that full, late-stage results for the closely-watched therapy may not be available for two years.'We are conducting some of the largest-scale trials ever in ...
|
|
|
Law Offices of Howard G. Smith, Representing Investors of Medivation, Inc., Announces Class Action Lawsuit
- Law Offices of Howard G.Smith, representing investors of Medivation, Inc. (Medivation or the Company) (Nasdaq:MDVN), has filed a class action lawsuit in United States District Court on behalf of a class (the Class) consisting of all persons or entities...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
|
|
University of Pennsylvania School of Medicine and AstraZeneca Working Together to Find New Therapies for Alzheimer's Disease
The University of Pennsylvania and AstraZeneca today announced a new collaborative research agreement to make use of their respective talents and resources in an effort to bridge the transition from drug discovery to development.Initially, the collaboration...
|
